At present, cervical screening will remain necessary in vaccinated populations owing to the relative type specificity of current vaccines. Falling population prevalence of cervical abnormalities will reduce the sensitivity and positive predictive value of cytological testing,23 and screening programmes will need to adapt to maintain their effectiveness. Our data suggest that this task is now becoming more urgent given the relatively rapid impact of the vaccine on disease in the real world setting. To tackle this, Australia is currently conducting a comprehensive review of cervical screening.24 Continued observation of this population is necessary to assess the implications for cervical screening recommendations in the coming era of mass vaccination.
Posted on: Wed, 12 Mar 2014 15:32:00 +0000
Trending Topics
Recently Viewed Topics
© 2015